RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-93

You have been time and again presenting the merits of Remestemcel-L on the prevention of deaths for >65 year olds.This forum cannot do anything for any Government to look beyond the current treatment applied and prevent further deaths. This is something MSB should be lobbying for and we have not seen any approaches being made by SI and his Board to even take their case to the Commonwealth Department of Health. Perhaps you should pose this question to SI.

It would be a tragedy if Governments do not put a value on lives of older people and are happy for them to pass on as it also means a savings in the cost of providing for them. I also recall that there were findings announced by MSB that claimed that Remestemcel-L was able to cure moderate to severe ARDS due to Covid infection and there were trials done which ultimately resulted in MSB's collaboration with Novartis. Although Novartis has pulled out there should be enough data to pursue this matter strenuously with the various approving bodies worldwide. So what is the world's foremost authority on stem cells doing to get its treatment approved that would save the lives of hundreds of thousands that you have mentioned.